Table 2 Patterns of resistance to first-line anti-tuberculosis drugs
From: Tuberculosis drug resistance in Bamako, Mali, from 2006 to 2014
Type of resistance | New patients (n = 236) n (%) | Previously treated patients (n = 101) n (%) |
|---|---|---|
Susceptible to all drugs | 193 (81.8) | 17 (16.8) |
Any resistance | ||
S | 25 (10.6) | 68 (67.3) |
I | 25 (10.6) | 76 (75.2) |
R | 10 (4.2) | 69 (68.3) |
E | 7 (3.0) | 52 (51.5) |
Monoresistance | ||
S | 13 (5.6) | 3 (3.0) |
I | 10 (4.2) | 2 (2.0) |
R | 1 (0.4) | 1 (1.0) |
E | 0 (0) | 1 (1.0) |
Total | 24 (10.2) | 7 (6.9) |
I + R resistant (MDR-TB) | ||
SIR | 0 (0) | 5 (5.0) |
IR | 3 (1.3) | 7 (6.9) |
IRE | 1 (0.4) | 4 (4.0) |
SIRE | 4 (1.7) | 51 (50.5) |
Total | 8 (3.4) | 67 (66.3) |
Other resistancea | ||
SI | 8 (3.4) | 8 (7.9) |
SIE | 1(0.4) | 2 (2.0) |
SR | 0 (0) | 1 (1.0) |
SRE | 1 (0.4) | 0 (0) |
Total | 10 (4.2) | 11 (10.9) |